Sign in
Back
Drug-resistant tuberculosis: pediatric guidelines
Journal article   Peer reviewed

Drug-resistant tuberculosis: pediatric guidelines

Mona Al-Dabbagh, Keswadee Lapphra, Rumi McGloin, Kelsey Inrig, H Simon Schaaf, Ben J Marais, Laura Sauve, Ian Kitai and Tobias R Kollmann
The Pediatric infectious disease journal, Vol.30(6), pp.501-505
06/2011
DOI: https://doi.org/10.1097/INF.0b013e31820b583d
PMID: 21297522

Abstract

Adolescent Antitubercular Agents - pharmacology Antitubercular Agents - therapeutic use Child Child, Preschool Drug Therapy, Combination - methods Humans Infant Infant, Newborn Mycobacterium tuberculosis - drug effects Mycobacterium tuberculosis - isolation & purification Pediatrics - methods Tuberculosis, Multidrug-Resistant - diagnosis Tuberculosis, Multidrug-Resistant - drug therapy
Drug-resistant Mycobacterium tuberculosis (TB) infection represents a serious and growing problem. For patients infected or suspected of being infected with multidrug or extensively drug-resistant TB, several medications have to be given simultaneously for prolonged periods. Here, we review the literature on treatment and monitoring of adverse effects of pediatric drug-resistant TB therapy in a high resource, low TB burden setting.

Metrics

1 Record Views

Details